Investing
1524 Articles
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into…
Both McDonald's and Pfizer are blue-chip laggards trading at a discount, both cut reliable dividend checks, and both promise retirees…
Jim Cramer stared down a stock yielding 7% and sitting near its 52-week low, and still would not tell viewers…
The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good…
Income investors watching the calendar have a narrow window this week. Three of the market’s most widely held high-yield names…
The S&P 500 keeps climbing, up nearly 9% year to date, and yet a handful of large-cap dividend payers are…
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality…
Healthcare has become Wall Street’s bargain bin in 2026, and value hunters are starting to pay attention. Drug pricing reform,…
Pre-Market Stock Futures: Futures are trading mixed as we get ready to start the first full week of trading for…
Passive income is the paycheck that arrives whether you show up or not. Wages depend on a functioning employer, a…
Volatility can lower the cost of entry into businesses that throw off real cash, even as investors recognize that a…
I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not…
Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction). The stock trades at $24.37, and…
At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before…
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending…
Our top personal finance-related articles today. Your wallet will thank you later.